192 related articles for article (PubMed ID: 33252581)
1. EFFECTS OF GLYCEMIC VARIABILITY ON THE PROGRESSION OF DIABETIC RETINOPATHY AMONG PATIENTS WITH TYPE 2 DIABETES.
Park JY; Hwang JH; Kang MJ; Sim HE; Kim JS; Ko KS
Retina; 2021 Jul; 41(7):1487-1495. PubMed ID: 33252581
[TBL] [Abstract][Full Text] [Related]
2. Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes.
Lu J; Ma X; Zhang L; Mo Y; Ying L; Lu W; Zhu W; Bao Y; Zhou J
J Diabetes Investig; 2019 May; 10(3):753-759. PubMed ID: 30306722
[TBL] [Abstract][Full Text] [Related]
3. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
4. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China.
Liu Y; Yang J; Tao L; Lv H; Jiang X; Zhang M; Li X
BMJ Open; 2017 Sep; 7(9):e016280. PubMed ID: 28864696
[TBL] [Abstract][Full Text] [Related]
5. Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy.
Zehetner C; Kirchmair R; Kralinger M; Kieselbach G
Acta Ophthalmol; 2013 Sep; 91(6):e470-3. PubMed ID: 23452413
[TBL] [Abstract][Full Text] [Related]
6. HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics.
Foo V; Quah J; Cheung G; Tan NC; Ma Zar KL; Chan CM; Lamoureux E; Tien Yin W; Tan G; Sabanayagam C
J Diabetes; 2017 Feb; 9(2):200-207. PubMed ID: 27043025
[TBL] [Abstract][Full Text] [Related]
7. Serum glycated albumin predicts the progression of diabetic retinopathy--a five year retrospective longitudinal study.
Pan J; Li Q; Zhang L; Jia L; Tang J; Bao Y; Jia W
J Diabetes Complications; 2014; 28(6):772-8. PubMed ID: 25073934
[TBL] [Abstract][Full Text] [Related]
8. The relationship between diabetic retinopathy, glycemic control, risk factor indicators and patient education.
Axer-Siegel R; Herscovici Z; Gabbay M; Mimouni K; Weinberger D; Gabbay U
Isr Med Assoc J; 2006 Aug; 8(8):523-6. PubMed ID: 16958239
[TBL] [Abstract][Full Text] [Related]
9. A five-year prospective study of diabetic retinopathy progression in chinese type 2 diabetes patients with "well-controlled" blood glucose.
Jin P; Peng J; Zou H; Wang W; Fu J; Shen B; Bai X; Xu X; Zhang X
PLoS One; 2015; 10(4):e0123449. PubMed ID: 25849536
[TBL] [Abstract][Full Text] [Related]
10. Clinical inertia causing new or progression of diabetic retinopathy in type 2 diabetes: A retrospective cohort study.
Osataphan S; Chalermchai T; Ngaosuwan K
J Diabetes; 2017 Mar; 9(3):267-274. PubMed ID: 27092709
[TBL] [Abstract][Full Text] [Related]
11. The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients.
Takao T; Ide T; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
Diabetes Res Clin Pract; 2011 Feb; 91(2):e40-2. PubMed ID: 21035886
[TBL] [Abstract][Full Text] [Related]
12. Diabetic retinopathy risk factors: plasma erythropoietin as a risk factor for proliferative diabetic retinopathy.
Gholamhossein Y; Behrouz H; Asghar Z
Korean J Ophthalmol; 2014 Oct; 28(5):373-8. PubMed ID: 25276078
[TBL] [Abstract][Full Text] [Related]
13. Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus.
Song KH; Jeong JS; Kim MK; Kwon HS; Baek KH; Ko SH; Ahn YB
J Diabetes Investig; 2019 May; 10(3):745-752. PubMed ID: 30300472
[TBL] [Abstract][Full Text] [Related]
14. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
[TBL] [Abstract][Full Text] [Related]
15. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
Hainsworth DP; Gao X; Bebu I; Das A; Olmos de Koo L; Barkmeier AJ; Tamborlane W; Lachin JM; Aiello LP;
Ophthalmology; 2021 Apr; 128(4):554-560. PubMed ID: 32941962
[TBL] [Abstract][Full Text] [Related]
16. Ethanolamine as a biomarker and biomarker-based therapy for diabetic retinopathy in glucose-well-controlled diabetic patients.
Hu G; Gu L; Wang R; Jian Q; Lv K; Xia M; Lai M; Shen T; Hu J; Yang S; Ye C; Zhang X; Wang Y; Xu X; Zhang F
Sci Bull (Beijing); 2024 Jun; 69(12):1920-1935. PubMed ID: 38423871
[TBL] [Abstract][Full Text] [Related]
17. Retinal main vessel calibers and systemic markers for long-term development of proliferative diabetic retinopathy.
Dinesen S; Stokholm L; Subhi Y; Henriksen JE; Savarimuthu TR; Peto T; Grauslund J
Acta Ophthalmol; 2024 Jun; 102(4):448-454. PubMed ID: 37803999
[TBL] [Abstract][Full Text] [Related]
18. Glycemic exposure and blood pressure influencing progression and remission of diabetic retinopathy: a longitudinal cohort study in GoDARTS.
Liu Y; Wang M; Morris AD; Doney AS; Leese GP; Pearson ER; Palmer CN
Diabetes Care; 2013 Dec; 36(12):3979-84. PubMed ID: 24170761
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors of diabetic retinopathy in subjects with suboptimal glycemic, blood pressure and lipid control. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, Report 33).
Raman R; Gupta A; Kulothungan V; Sharma T
Curr Eye Res; 2012 Jun; 37(6):513-23. PubMed ID: 22577770
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for progression of diabetic retinopathy in Alberta First Nations communities.
Rudnisky CJ; Wong BK; Virani H; Tennant MTS
Can J Ophthalmol; 2017 Nov; 52 Suppl 1():S19-S29. PubMed ID: 29074008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
